121 related articles for article (PubMed ID: 19203718)
1. Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes.
Raghu KG; Cherian OL
J Trace Elem Med Biol; 2009; 23(1):61-8. PubMed ID: 19203718
[TBL] [Abstract][Full Text] [Related]
2. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Paul MK; Kumar R; Mukhopadhyay AK
Toxicol Appl Pharmacol; 2008 Jan; 226(2):140-52. PubMed ID: 18022205
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide toxicity in H9c2 myoblasts--damage to cell organelles and possible amelioration with Boerhavia diffusa.
Vineetha VP; Prathapan A; Soumya RS; Raghu KG
Cardiovasc Toxicol; 2013 Jun; 13(2):123-37. PubMed ID: 23161055
[TBL] [Abstract][Full Text] [Related]
4. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A
Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216
[TBL] [Abstract][Full Text] [Related]
5. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide.
Mathews VV; Paul MV; Abhilash M; Manju A; Abhilash S; Nair RH
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():34-8. PubMed ID: 23436664
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug.
Raghu KG; Yadav GK; Singh R; Prathapan A; Sharma S; Bhadauria S
J Environ Pathol Toxicol Oncol; 2009; 28(3):241-52. PubMed ID: 19888912
[TBL] [Abstract][Full Text] [Related]
7. Morphine Attenuated the Cytotoxicity Induced by Arsenic Trioxide in H9c2 Cardiomyocytes.
Amini-Khoei H; Hosseini MJ; Momeny M; Rahimi-Balaei M; Amiri S; Haj-Mirzaian A; Khedri M; Jahanabadi S; Mohammadi-Asl A; Mehr SE; Dehpour AR
Biol Trace Elem Res; 2016 Sep; 173(1):132-9. PubMed ID: 26815588
[TBL] [Abstract][Full Text] [Related]
8. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
Li L; Wang J; Ye RD; Shi G; Jin H; Tang X; Yi J
J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells.
Wang J; Li L; Cang H; Shi G; Yi J
Leuk Res; 2008 Mar; 32(3):429-36. PubMed ID: 17804067
[TBL] [Abstract][Full Text] [Related]
11. Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity.
Vineetha VP; Girija S; Soumya RS; Raghu KG
Food Funct; 2014 Mar; 5(3):502-11. PubMed ID: 24441683
[TBL] [Abstract][Full Text] [Related]
12. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity.
Zhao X; Feng T; Chen H; Shan H; Zhang Y; Lu Y; Yang B
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):419-25. PubMed ID: 18346055
[TBL] [Abstract][Full Text] [Related]
14. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
[TBL] [Abstract][Full Text] [Related]
15. Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis.
Fan Y; Wang C; Zhang Y; Hang P; Liu Y; Pan Z; Wang N; Du Z
Cell Physiol Biochem; 2013; 31(1):80-91. PubMed ID: 23363563
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells.
Bessho M; Aki T; Funakoshi T; Unuma K; Noritake K; Kato C; Uemura K
Cardiovasc Toxicol; 2013 Sep; 13(3):267-77. PubMed ID: 23532581
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
18. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
Wang Z; Zhang H; Dai L; Song T; Li P; Liu Y; Wang L
Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Han YH; Kim SZ; Kim SH; Park WH
Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
